# US 2021/0330730 A1 · Traditional Chinese Medicine Composition For Treating Type 2 Diabetes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330730 A1
- Document ID: US20210330730A1
- Status: Published application
- Kind: A1
- Application number: 17/120,207
- Filed: 2020-12-13
- Published: 2021-10-28
- Earliest claimed: 2020-04-26
- Inventors: Jinchang Ai
- Web page: https://patentgrep.com/patent/US20210330730A1

## CPC

- A61K 36/07: Basidiomycota, e.g. Cryptococcus
- A61K 36/11: Pteridophyta or Filicophyta (ferns)
- A61K 36/12: Filicopsida or Pteridopsida
- A61K 36/258: Panax (ginseng)
- A61K 36/288: Taraxacum (dandelion)
- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/605: Morus (mulberry)
- A61K 36/73: Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 36/85: Verbenaceae (Verbena family)
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The application discloses a traditional Chinese medicine composition for treating of type 2 diabetes, comprising the following raw materials: wild Descolor Cinquefoil Herb, wild Rhizoma imperatae, wild Root and Rhizome of Japanese Climbing Fern, Ginseng leaf (over 7 years), wild Rough Melic, wild Vitex negundo L., Morus alba L., green tea, wild auricularia, corn silk, dandelion root. The traditional Chinese medicine composition of the application is suitable for patients with type 2 diabetes and complications of type 2 diabetes, which has no adverse reactions and stable curative effect.

## Claims

### Claim 1

A pharmaceutical composition for treating type 2 diabetes, comprising the following raw materials: wild Descolor Cinquefoil Herb, wild Rhizoma imperatae, wild Root and Rhizome of Japanese Climbing Fern, Ginseng leaf (over 7 years), wild Rough Melic, wild Vitex negundo L., Morus alba L., green tea, wild auricularia, corn silk, dandelion root.

### Claim 2 (depends on 1)

The pharmaceutical composition for treating type 2 diabetes according to claim 1, wherein comprising the following weight ratio of raw materials: 15-25 g wild Descolor Cinquefoil Herb, 15-25 g wild Rhizoma imperatae, 15-25 g wild Root and Rhizome of Japanese Climbing Fern, 10-20 g Ginseng leaf (over 7 years), 10-20 g wild Rough Melic, 10-20 g wild Vitex negundo L., 10-20 g Morus alba L., 10-20 g green tea, 10-20 g wild auricularia, 10-20 g corn silk, 10-20 g dandelion root.

### Claim 3 (depends on 2)

The pharmaceutical composition for treating type 2 diabetes according to claim 2, wherein comprising the following weight ratio of raw materials: 15 g wild Descolor Cinquefoil Herb, 15 g wild Rhizoma imperatae, 15 g wild Root and Rhizome of Japanese Climbing Fern, 10 g Ginseng leaf (over 7 years), 10 g wild Rough Melic, 10 g wild Vitex negundo L., 10 g Morus alba L., 10 g green tea, 10 g wild auricularia, 10 g corn silk, 10 g dandelion root.

### Claim 4 (depends on 2)

The pharmaceutical composition for treating type 2 diabetes according to claim 2, wherein comprising the following weight ratio of raw materials: 25 g wild Descolor Cinquefoil Herb, 25 g wild Rhizoma imperatae, 25 g wild Root and Rhizome of Japanese Climbing Fern, 20 g Ginseng leaf (over 7 years), 20 g wild Rough Melic, 20 g wild Vitex negundo L., 20 g Morus alba L., 20 g green tea, 20 g wild auricularia, 20 g corn silk, 20 g dandelion root.

### Claim 5 (depends on 2)

The pharmaceutical composition for treating type 2 diabetes according to claim 2, wherein comprising the following weight ratio of raw materials: 20 g wild Descolor Cinquefoil Herb, 20 g wild Rhizoma imperatae, 20 g wild Root and Rhizome of Japanese Climbing Fern, 15 g Ginseng leaf (over 7 years), 15 g wild Rough Melic, 15 g wild Vitex negundo L., 15 g Morus alba L., 15 g green tea, 15 g wild auricularia, 15 g corn silk, 15 g dandelion root.

### Claim 6 (depends on 1)

The pharmaceutical composition for treating type 2 diabetes according to claim 1, wherein traditional Chinese medicine composition is in the form of decoctions, powders, pills or capsules.

### Claim 7 (depends on 6)

The pharmaceutical composition for treating type 2 diabetes according to claim 6, wherein comprising the following weight ratio of raw materials: 15-25 g wild Descolor Cinquefoil Herb, 15-25 g wild Rhizoma imperatae, 15-25 g wild Root and Rhizome of Japanese Climbing Fern, 10-20 g Ginseng leaf (over 7 years), 10-20 g wild Rough Melic, 10-20 g wild Vitex negundo L., 10-20 g Morus alba L., 10-20 g green tea, 10-20 g wild auricularia, 10-20 g corn silk, 10-20 g dandelion root.

### Claim 8 (depends on 6)

The pharmaceutical composition for treating type 2 diabetes according to claim 6, wherein comprising the following weight ratio of raw materials: 15 g wild Descolor Cinquefoil Herb, 15 g wild Rhizoma imperatae, 15 g wild Root and Rhizome of Japanese Climbing Fern, 10 g Ginseng leaf (over 7 years), 10 g wild Rough Melic, 10 g wild Vitex negundo L., 10 g Morus alba L., 10 g green tea, 10 g wild auricularia, 10 g corn silk, 10 g dandelion root.

### Claim 9 (depends on 6)

The pharmaceutical composition for treating type 2 diabetes according to claim 6, wherein comprising the following weight ratio of raw materials: 25 g wild Descolor Cinquefoil Herb, 25 g wild Rhizoma imperatae, 25 g wild Root and Rhizome of Japanese Climbing Fern, 20 g Ginseng leaf (over 7 years), 20 g wild Rough Melic, 20 g wild Vitex negundo L., 20 g Morus alba L., 20 g green tea, 20 g wild auricularia, 20 g corn silk, 20 g dandelion root.

### Claim 10 (depends on 6)

The pharmaceutical composition for treating type 2 diabetes according to claim 6, wherein comprising the following weight ratio of raw materials: 20 g wild Descolor Cinquefoil Herb, 20 g wild Rhizoma imperatae, 20 g wild Root and Rhizome of Japanese Climbing Fern, 15 g Ginseng leaf (over 7 years), 15 g wild Rough Melic, 15 g wild Vitex negundo L., 15 g Morus alba L., 15 g green tea, 15 g wild auricularia, 15 g corn silk, 15 g dandelion root.

### Claim 11 (depends on 1)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 1 to said subject in need of such treatment.

### Claim 12 (depends on 2)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 2 to said subject in need of such treatment.

### Claim 13 (depends on 3)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 3 to said subject in need of such treatment.

### Claim 14 (depends on 4)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 4 to said subject in need of such treatment.

### Claim 15 (depends on 5)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 5 to said subject in need of such treatment.

### Claim 16 (depends on 6)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 6 to said subject in need of such treatment.

### Claim 17 (depends on 7)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 7 to said subject in need of such treatment.

### Claim 18 (depends on 8)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 8 to said subject in need of such treatment.

### Claim 19 (depends on 9)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 9 to said subject in need of such treatment.

### Claim 20 (depends on 10)

A method for treating type 2 diabetes in a subject, comprising administrating the composition of claim 10 to said subject in need of such treatment.
